Michael Cobble Selected Research

Michael Cobble Research Topics

2	Type 2 Diabetes Mellitus (MODY) 03/2012 - 01/2012
2	Weight Loss (Weight Reduction) 03/2012 - 01/2012
1	Hypertriglyceridemia 03/2020
1	Neoplasms (Cancer) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2019
1	Drug-Related Side Effects and Adverse Reactions 02/2014
1	Nasopharyngitis 03/2012
1	Dyslipidemias (Dyslipidemia) 01/2012
1	Inflammation (Inflammations) 01/2012
1	Hypertension (High Blood Pressure) 01/2012
1	Obesity 01/2012
1	Atherosclerosis 01/2010

2	Glucagon-Like Peptide-1 ReceptorIBA 03/2012 - 01/2012
2	LipidsIBA 01/2012 - 01/2010
1	CholesterolIBA 03/2020
1	Vitamin D FDA LinkGeneric 12/2019
1	Cholecalciferol (Vitamin D3)FDA Link 12/2019
1	oxidized low density lipoproteinIBA 02/2014
1	Antihypertensive Agents (Antihypertensives)IBA 02/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2012
1	Dipeptidyl-Peptidase IV InhibitorsIBA 03/2012
1	IncretinsIBA 03/2012
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2012
1	Exenatide (Byetta)FDA Link 01/2012
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2012
1	ApolipoproteinsIBA 01/2012
1	Lipoproteins (Lipoprotein)IBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	Insulin (Novolin)FDA Link 01/2010

2	Therapeutics 02/2014 - 03/2012
1	Glycemic Control 01/2012